MODIFICATION
99 -- FeverPhone 2.0 - Point-of-Care Differential Diagnosis of Hemorrhagic Fevers.
- Notice Date
- 7/11/2023 10:01:13 AM
- Notice Type
- Sources Sought
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ARMY MED RES ACQ ACTIVITY FORT DETRICK MD 21702 USA
- ZIP Code
- 21702
- Solicitation Number
- HT942523C_
- Response Due
- 7/17/2023 10:00:00 AM
- Archive Date
- 07/18/2023
- Point of Contact
- Deborah Hagan, Phone: 3016192396, Elizabeth O'Hara, Phone: 3016192278
- E-Mail Address
-
Deborah.L.Hagan.civ@health.mil, elizabeth.m.ohara3.civ@health.mil
(Deborah.L.Hagan.civ@health.mil, elizabeth.m.ohara3.civ@health.mil)
- Description
- The primary objective of this requirement is to develop and verify a point-of-care device for detection of both antigen and antibody biomarkers of Ebola, Lassa, and Marburg virus utilizing Cornell University�s patented FeverPhone technology. To date, there are no multiplexed protein detection assays for the point-of-care that target a panel of hemorrhagic fever viruses. Preliminary work by Cornell University on a separate funded effort for tropical fever virus multiplexed detection (Dengue and Chikungunya) has resulted in data demonstrating that their proprietary technology/concepts work for point-of-care detection of antigens and antibodies from viral infection.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/912d2dbf983d4eb587b4c405c4670088/view)
- Place of Performance
- Address: Ithaca, NY 14853, USA
- Zip Code: 14853
- Country: USA
- Zip Code: 14853
- Record
- SN06743271-F 20230713/230711230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |